Throughout 20242025, major biotech deals reshaped the landscape: Roche/Zealand (Dec 2024) A Reuters report announced Roche would pay $1.65B upfront (up to $5.3B including milestones) for rights to Zealand Pharmas amylin analog petrelintide , testing in obesity ( [13] )
Part of why I wrote a 20,000-word page about MCAS is because I know well what it is like to not have reliable, accessible information, and I wanted to share my personal experiences and research notes in case they supported someone else
This review looks at how each program is built, how their medication and pricing models differ, and the one metabolic variable that sits outside both platforms
Other sources suggest a range up to 36 months (3 years) when stored under optimal conditions
Psychological Bulletin, 1976
Hangover IV Bounce back fast